International Journal of Cancer最新文献

筛选
英文 中文
Clinical Utility of Cytological Methylation Assay in Cervical Cancer Screening Across Various Cervical Transformation Zones. 细胞学甲基化检测在不同宫颈转化区宫颈癌筛查中的临床应用
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-15 Epub Date: 2026-06-11 DOI: 10.1002/ijc.70591
Xiaoying Zhong, Xitong Jin, Yanan Cheng, Xiaopei Chao, Linghua Kong, Jing Wang, Pei Liu, Yuligh Liou, Demei Xin, Jinghe Lang, Lei Li
{"title":"Clinical Utility of Cytological Methylation Assay in Cervical Cancer Screening Across Various Cervical Transformation Zones.","authors":"Xiaoying Zhong, Xitong Jin, Yanan Cheng, Xiaopei Chao, Linghua Kong, Jing Wang, Pei Liu, Yuligh Liou, Demei Xin, Jinghe Lang, Lei Li","doi":"10.1002/ijc.70591","DOIUrl":"10.1002/ijc.70591","url":null,"abstract":"<p><p>Type I to III cervical transformation zones (TZ-1 to TZ-3) may have various effects on cervical cancer screening and diagnostic outcomes. This study aims to evaluate the clinical utility of the cytological PAX1/JAM3 methylation (CISCER) assay in cervical cancer screening, especially in TZ-3 women. Between November 2020 and October 2022, 1782 women referred for colposcopy underwent liquid-based cytology (LBC), high-risk human papillomavirus (hrHPV) genotyping, and CISCER testing. After applying inclusion criteria, 1398 women were analyzed, including 1190 with documented TZ classification. Diagnostic performance for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3+) was compared across TZ subgroups. For CIN3+ detection, CISCER showed sensitivities of 67.4%, 72.0%, 48.3%, and 81.5% and specificities of 91.0%, 94.2%, 91.3%, and 89.8% in all women, TZ-1, TZ-2, and TZ-3, respectively. Compared with LBC ≥ ASC-US, hrHPV positivity, or HPV16/18 positivity, CISCER achieved the highest diagnostic accuracy, with AUC values of 0.792, 0.831, 0.698, and 0.856 across the respective groups. In both the overall cohort and TZ-3 subgroup, CISCER positivity was associated with the highest CIN3+ risk (34.6% and 31.4%) and required the fewest colposcopy referrals per CIN3+ detected (2.9 and 3.2). Combining hrHPV testing with CISCER further improved risk stratification. CISCER demonstrated superior diagnostic performance across TZ types, particularly in TZ-3, enabling improved CIN3+ risk discrimination while substantially reducing unnecessary colposcopy referrals compared with conventional cytology and HPV genotyping.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2084-2096"},"PeriodicalIF":4.9,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13495850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148222228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to "Comments on Development and Psychometric Properties of a General Cancer Stigma Scale (COMPASS)". 回复“一般癌症耻感量表(COMPASS)的编制及心理测量性质的意见”。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-15 Epub Date: 2026-05-26 DOI: 10.1002/ijc.70569
Stephen M Kimani, Gita Suneja, Melissa A Stockton, Brandon A Knettel, Melissa H Watt
{"title":"Reply to \"Comments on Development and Psychometric Properties of a General Cancer Stigma Scale (COMPASS)\".","authors":"Stephen M Kimani, Gita Suneja, Melissa A Stockton, Brandon A Knettel, Melissa H Watt","doi":"10.1002/ijc.70569","DOIUrl":"10.1002/ijc.70569","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2099-2100"},"PeriodicalIF":4.9,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13495797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148025293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "Development and Psychometric Properties of a General Cancer Stigma Scale (COMPASS)". 对“通用癌症耻感量表(COMPASS)的编制和心理测量学性质”的评论。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-15 Epub Date: 2026-05-26 DOI: 10.1002/ijc.70570
Satya Ranjan Misra, Rupsa Das
{"title":"Comments on \"Development and Psychometric Properties of a General Cancer Stigma Scale (COMPASS)\".","authors":"Satya Ranjan Misra, Rupsa Das","doi":"10.1002/ijc.70570","DOIUrl":"10.1002/ijc.70570","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2097-2098"},"PeriodicalIF":4.9,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13495837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148025349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial. 血浆PlGF作为晚期胃食管腺癌基于RAMIRIS试验II期部分探索性生物标志物分析的潜在生物标志物
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-01 Epub Date: 2026-06-09 DOI: 10.1002/ijc.70567
Jurek Hille, Sylvie Lorenzen, Claudia Pauligk, Victoria Gensch, Peter Thuss-Patience, Eray Goekkurt, Thomas Ettrich, Florian Lordick, Carsten Bokemeyer, Christian Müller, Peter Reichardt, Martin Sökler, Daniel Pink, Stefan Probst, Thorsten O Goetze, Salah E Al-Batran, Sonja Loges, Melanie Janning
{"title":"Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial.","authors":"Jurek Hille, Sylvie Lorenzen, Claudia Pauligk, Victoria Gensch, Peter Thuss-Patience, Eray Goekkurt, Thomas Ettrich, Florian Lordick, Carsten Bokemeyer, Christian Müller, Peter Reichardt, Martin Sökler, Daniel Pink, Stefan Probst, Thorsten O Goetze, Salah E Al-Batran, Sonja Loges, Melanie Janning","doi":"10.1002/ijc.70567","DOIUrl":"10.1002/ijc.70567","url":null,"abstract":"<p><p>Antiangiogenic treatment with ramucirumab (RAM) is a standard second-line option in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma. However, reliable biomarkers are lacking. The phase II RAMIRIS trial compared RAM plus paclitaxel with RAM plus FOLFIRI (5-fluororuracil, leucovorin and irinotecan) in this setting. We present the exploratory biomarker analysis evaluating placental growth factor (PlGF), carbonic anhydrase IX (CAIX), and tryptase. Plasma samples from 99 patients enrolled in RAMIRIS were collected at predefined timepoints (baseline, Cycle 2 Day 1, and Cycle 4 Day 1). PlGF, CAIX, and tryptase were quantified by ELISA. Associations with progression-free survival (PFS) and overall survival (OS) were analyzed using dichotomized biomarker levels and Cox regression models. PlGF levels increased substantially under treatment, whereas CAIX showed a transient rise, followed by a slight decline, and tryptase remained stable. Elevated PlGF levels at baseline and early-treatment (c2d1) were associated with shorter OS in univariate analysis (baseline HR<sub>u</sub> = 1.75; p = 0.020; c2d1 HR<sub>u</sub> = 1.69; p = 0.054). After multivariate adjustment, the association remained directionally consistent; although statistical support was retained only for c2d1 (baseline HR<sub>m</sub> = 1.41, p = 0.198; c2d1 HR<sub>m</sub> = 1.85, p = 0.030). CAIX and tryptase showed no consistent associations with survival. Elevated PlGF-particularly its early increase during RAM-based therapy-was associated with shortened survival and may represent a dynamic marker of unfavorable prognosis in advanced gastric/GEJ adenocarcinoma. Given the exploratory nature of this analysis, these findings should be considered hypothesis-generating and require validation in independent biomarker-driven studies.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1817-1828"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13432362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148209534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients. 一种血清lncRNA特征决定了癌症患者的致癌YAP活性。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-01 Epub Date: 2026-06-23 DOI: 10.1002/ijc.70584
Fabian Rose, Nada El-Ekiaby, Lilija Wehling, Sofia Maria Elisabeth Weiler, Jennifer Schmitt, Marcell Tóth, Fabiola Pedrini, Amruta Damle-Vartak, Carsten Sticht, Rossella Pellegrino, Injie Omar Fawzy, Merna Hatem Mohamed Hamad, Mohamed Negm, Dina Omar, Hossam Eldeen Soliman, Gamal Esmat, Thomas Longerich, Thomas Illig, Bruno Christian Köhler, Anna Saborowski, Heike Bantel, Arndt Vogel, Peter Schirmacher, Ahmed Ihab Abdelaziz, Kai Breuhahn
{"title":"A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.","authors":"Fabian Rose, Nada El-Ekiaby, Lilija Wehling, Sofia Maria Elisabeth Weiler, Jennifer Schmitt, Marcell Tóth, Fabiola Pedrini, Amruta Damle-Vartak, Carsten Sticht, Rossella Pellegrino, Injie Omar Fawzy, Merna Hatem Mohamed Hamad, Mohamed Negm, Dina Omar, Hossam Eldeen Soliman, Gamal Esmat, Thomas Longerich, Thomas Illig, Bruno Christian Köhler, Anna Saborowski, Heike Bantel, Arndt Vogel, Peter Schirmacher, Ahmed Ihab Abdelaziz, Kai Breuhahn","doi":"10.1002/ijc.70584","DOIUrl":"10.1002/ijc.70584","url":null,"abstract":"<p><p>Biomarkers are typically identified by comparing human samples such as tissues and serum. However, reliable markers for transcriptionally active oncogenes remain elusive due to tumor heterogeneity and confounding signals from non-tumorous cells. We hypothesize that in vitro screening is sufficient to identify a long non-coding RNA (lncRNA) signature that is a specific marker for oncogenic transcriptional regulators. Exemplified for the Hippo pathway effectors, we integrated experimental NGS and cancer patient expression data with bioinformatics approaches to identify a yes-associated protein (YAP)-specific lncRNA signature in hepatocellular carcinoma (HCC) cells. The lncRNAs in this signature include CYTOR, MIR4435-2HG, SNHG1, and SNHG17, which partly promote HCC cell proliferation and control the sensitivity to YAP/TEA domain transcription factor (TEAD)-targeted inhibition. In HCC tissues, the lncRNA signature is associated with increased nuclear enrichment of YAP, the expression of YAP target genes, and poor clinical outcomes in patients. This association was also confirmed in cells and tissues of other malignancies, including lung adenocarcinoma (LUAD). Notably, the lncRNA signature is detectable in the serum of HCC patients and predicts YAP activation in tumor tissues. In summary, the Hippo pathway-associated lncRNA signature provides a readout for oncogenic YAP activity across cancers, suggesting its potential as a pan-cancer biomarker. Our results highlight oncogene-specific lncRNA signatures as valuable tools for diagnostics, therapy selection, and treatment monitoring.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1829-1843"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13432287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148306279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "Prior Immunotherapy Enhances Survival Outcomes of Third-Line Apatinib Treatment in Advanced Gastric Cancer: A Retrospective Cohort Study". “既往免疫治疗提高三线阿帕替尼治疗晚期胃癌的生存结局:一项回顾性队列研究”。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-10-01 Epub Date: 2026-05-25 DOI: 10.1002/ijc.70568
Heng Xu, Jiaan Lu
{"title":"Comments on \"Prior Immunotherapy Enhances Survival Outcomes of Third-Line Apatinib Treatment in Advanced Gastric Cancer: A Retrospective Cohort Study\".","authors":"Heng Xu, Jiaan Lu","doi":"10.1002/ijc.70568","DOIUrl":"10.1002/ijc.70568","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1844-1845"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13432336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148012871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "FHL2 Expression by Cancer-Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma". 更正“肿瘤相关成纤维细胞表达FHL2促进肺腺癌转移和血管生成”。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-09-15 Epub Date: 2026-06-15 DOI: 10.1002/ijc.70597
{"title":"Correction to \"FHL<sub>2</sub> Expression by Cancer-Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma\".","authors":"","doi":"10.1002/ijc.70597","DOIUrl":"10.1002/ijc.70597","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1570-1571"},"PeriodicalIF":4.9,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13397200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148248137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta-Analysis of Over 720,000 Participants in the ABACus 2 Consortium". 《成人BMI与癌症风险的敏感期分析:ABACus 2联盟中超过72万名参与者的个体数据荟萃分析》
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-09-15 Epub Date: 2026-05-25 DOI: 10.1002/ijc.70566
Gong Zhang
{"title":"Comments on \"Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta-Analysis of Over 720,000 Participants in the ABACus 2 Consortium\".","authors":"Gong Zhang","doi":"10.1002/ijc.70566","DOIUrl":"10.1002/ijc.70566","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1568-1569"},"PeriodicalIF":4.9,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13397142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148012842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Geographical and Spatial Disparities in the Incidence and Survival of Rare Cancers in Australia". 更正“澳大利亚罕见癌症发病率和生存率的地理和空间差异”。
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-09-15 Epub Date: 2026-06-15 DOI: 10.1002/ijc.70598
{"title":"Correction to \"Geographical and Spatial Disparities in the Incidence and Survival of Rare Cancers in Australia\".","authors":"","doi":"10.1002/ijc.70598","DOIUrl":"10.1002/ijc.70598","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1572"},"PeriodicalIF":4.9,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13397141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148248266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPRESSION OF CONCERN: Overlapping and Distinct Role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 Axes in Regulating Metastatic Behavior of Human Rhabdomyosarcomas. 关注表达:CXCR7-SDF-1/ITAC和CXCR4-SDF-1轴在调节人横纹肌肉瘤转移行为中的重叠和独特作用
IF 4.9 2区 医学
International Journal of Cancer Pub Date : 2026-09-15 Epub Date: 2026-05-31 DOI: 10.1002/ijc.70556
{"title":"EXPRESSION OF CONCERN: Overlapping and Distinct Role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 Axes in Regulating Metastatic Behavior of Human Rhabdomyosarcomas.","authors":"","doi":"10.1002/ijc.70556","DOIUrl":"10.1002/ijc.70556","url":null,"abstract":"<p><strong>Expression of concern: </strong>K. Grymula, M. Tarnowski, M. Wysoczynski, J. Drukala, F. G. Barr, J. Ratajczak, M. Kucia, and M. Z. Ratajczak, \"Overlapping and Distinct Role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 Axes in Regulating Metastatic Behavior of Human Rhabdomyosarcomas,\" International Journal of Cancer 127, no. 11 (2010): 2554-2568, https://doi.org/10.1002/ijc.25245. This Expression of Concern is for the above article, published online on 16 February 2010 and available in Wiley Online Library (wileyonlinelibrary.com), and has been published by agreement between the journal Editor-in-Chief, Prof. Christoph Plass; the Union for International Cancer Control; and John Wiley & Sons Ltd. The Expression of Concern was agreed due to concerns raised by a third party after publication regarding the similarity of certain blots in Figures 1c & 1d and the underlying data that they represent. This affects the two T-MAPK 42/44 panels in the c) CW9019 ARMS and d) RD EMRS cell lines. The corresponding author, M. Z. Ratajczak, confirmed the similarity of the two panels in Figure 1 but could not provide the original data given the time that had elapsed. An investigation by the University of Louisville concluded that falsification of the data was likely. However, this could not be confirmed due to the lack of original data. The journal has decided to issue this Expression of Concern to alert the readers to these unresolved concerns regarding the integrity of the data and the results presented. The authors M. Z. Ratajczak, M. Wysoczynski, and F. G. Barr agree to this Expression of Concern. K. Grymula, M. Tarnowski, J. Drukala, J. Ratajczak, and M. Kucia were not reachable.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1573"},"PeriodicalIF":4.9,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13397316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148136032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书